標(biāo)題: Titlebook: Biopharmaceuticals, an Industrial Perspective; Gary Walsh,Brendan Murphy Book 1999 Springer Science+Business Media B.V. 1999 biochemistry. [打印本頁] 作者: 門牙 時間: 2025-3-21 19:49
書目名稱Biopharmaceuticals, an Industrial Perspective影響因子(影響力)
書目名稱Biopharmaceuticals, an Industrial Perspective影響因子(影響力)學(xué)科排名
書目名稱Biopharmaceuticals, an Industrial Perspective網(wǎng)絡(luò)公開度
書目名稱Biopharmaceuticals, an Industrial Perspective網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biopharmaceuticals, an Industrial Perspective被引頻次
書目名稱Biopharmaceuticals, an Industrial Perspective被引頻次學(xué)科排名
書目名稱Biopharmaceuticals, an Industrial Perspective年度引用
書目名稱Biopharmaceuticals, an Industrial Perspective年度引用學(xué)科排名
書目名稱Biopharmaceuticals, an Industrial Perspective讀者反饋
書目名稱Biopharmaceuticals, an Industrial Perspective讀者反饋學(xué)科排名
作者: JOT 時間: 2025-3-21 23:13 作者: 繁殖 時間: 2025-3-22 02:37
Laser in der Medizin / Laser in Medicine reported being mild to moderate bone pain. Current issues being investigated include evaluation of the cost benefit of Filgrastim in various clinical settings and impact on survival in dose-intensive chemotherapy with Filgrastim given as an adjunct treatment.作者: 厚顏無恥 時間: 2025-3-22 07:07
Laser in der Medizin / Laser in Medicineset of activity and a shorter duration of action when compared to regular human insulin while maintaining equal glucose lowering ability. Insulin lispro provides better postprandial glucose control at a more convenient time relative to consumption of a meal.作者: Bumble 時間: 2025-3-22 12:34
Arbeitsgruppe Neuhaus/Borkowski/Lietzg regimen. Clinical studies comparing reteplase with the current standard thrombolytic agents have demonstrated that reteplase has a highly favourable pharmacological profile with prolonged half-life, low bleeding risk and low potential for antigenicity.作者: 協(xié)定 時間: 2025-3-22 16:24
Biopharmaceutical Drug Development: A Case History, reported being mild to moderate bone pain. Current issues being investigated include evaluation of the cost benefit of Filgrastim in various clinical settings and impact on survival in dose-intensive chemotherapy with Filgrastim given as an adjunct treatment.作者: OFF 時間: 2025-3-22 17:04
Insulin Lispro (Humalog),set of activity and a shorter duration of action when compared to regular human insulin while maintaining equal glucose lowering ability. Insulin lispro provides better postprandial glucose control at a more convenient time relative to consumption of a meal.作者: 慎重 時間: 2025-3-22 23:26
Reteplase, a recombinant plasminogen activator,g regimen. Clinical studies comparing reteplase with the current standard thrombolytic agents have demonstrated that reteplase has a highly favourable pharmacological profile with prolonged half-life, low bleeding risk and low potential for antigenicity.作者: 偏狂癥 時間: 2025-3-23 03:30
Book 1999 and alliedprofessionals already employed in the biopharmaceutical industry, orto those seeking employment within this industry. Its scope alsorenders it an ideal reference source for students undertaking advancedundergraduate or postgraduate courses in biotechnology, pharmaceuticalscience, biochemistry or medicine.作者: 組裝 時間: 2025-3-23 07:34
Laser in der Medizin / Laser in Medicineinant FSH is more effective and efficient in ovarian stimulation, eventually leading to a higher chance for a pregnancy, than the traditional FSH derived from postmenopausal urine. In this chapter, various aspects on the molecular biology, pharmacokinetics, preclinal tests, and clinical trials are addressed.作者: 樂器演奏者 時間: 2025-3-23 11:04 作者: PRE 時間: 2025-3-23 16:54
Einleitung: Laser in der Umweltme?techniking noted, its potential has not yet been realised in large scale clinical trials. Critical areas for future development remain in the design of more efficient, safer, vectors for gene delivery. Viral vectors are currently undergoing extensive modifications to produce vectors custom-made for particular clinical applications.作者: 我怕被刺穿 時間: 2025-3-23 18:39 作者: 脫水 時間: 2025-3-24 00:42
Viral mediated gene therapy,ing noted, its potential has not yet been realised in large scale clinical trials. Critical areas for future development remain in the design of more efficient, safer, vectors for gene delivery. Viral vectors are currently undergoing extensive modifications to produce vectors custom-made for particular clinical applications.作者: 細(xì)胞 時間: 2025-3-24 02:43 作者: Arable 時間: 2025-3-24 09:52
Laser in der Medizin / Laser in Medicinebstances produced by modem biotechnological techniques. Thus far, in excess of 50 such substances have gained regulatory approval for medical use. All are proteins produced by recombinant DNA technology or (in the case of monoclonal antibodies) by hybridoma technology..Biopharmaceuticals approved to作者: 分期付款 時間: 2025-3-24 11:58
Laser in der Medizin / Laser in Medicinerdial infarction and unstable angina pectoris. Although aspirin has traditionally been the mainstay of antiplatelet therapy, it is neither potent nor specific enough to provide adequate protection against thrombosis. The identification of glycoprotein (GP) IIb/IIIa as the key platelet receptor in th作者: 享樂主義者 時間: 2025-3-24 18:14
Laser in der Medizin / Laser in Medicineercome problems associated with plasma-derived blood products, Genetics Institute developed a recombinant coagulation factor IX (rFIX, BeneFIX.) produced using a Chinese hamster ovary cell line. The production cell line includes an rFIX expression vector as well as another plasmid expressing PACE-SO作者: Notorious 時間: 2025-3-24 21:14 作者: 鑲嵌細(xì)工 時間: 2025-3-25 02:41
Laser in der Medizin / Laser in Medicinewere transfected with genes encoding for the α- and β- subunit of FSH. The production of the amino-acid backbone and the very essential post-translational glycosylation process results in a human FSH virtually identical to natural human pituitary FSH. In clinical trials it was shown that this recomb作者: 蚊帳 時間: 2025-3-25 07:25 作者: slipped-disk 時間: 2025-3-25 10:09 作者: anniversary 時間: 2025-3-25 12:48
Arbeitsgruppe Neuhaus/Borkowski/Lietzd and complete recanalization of infarct-related coronary arteries may lead to greater survival benefits than achieved by current therapies. Furthermore, first-and second-generation thrombolytics can be associated with side effects, such as bleeding complications, and often require prolonged infusio作者: 死亡 時間: 2025-3-25 18:43 作者: DEI 時間: 2025-3-25 20:19
M. Poetke,C. Philipp,H.-P. Berlienstry, and biotechnology in all their many sub-categories. To be patentable, biopharmaceuticals and their processes of manufacture have to meet the same three legal tests of novelty, inventiveness, and practical utility as do the simpler compounds and preparative methods of synthetic chemistry. As fo作者: kyphoplasty 時間: 2025-3-26 02:55 作者: Servile 時間: 2025-3-26 04:41 作者: 使厭惡 時間: 2025-3-26 12:16 作者: 不透明性 時間: 2025-3-26 13:45
Laser in der Technik / Laser in Engineering use. It is often fruitless and costly to begin developing marketing programs and spending money in advance of making careful and global strategic assessment. This chapter focusses on this and related issues central to the successful marketing of (bio)pharmaceutical products.作者: Paradox 時間: 2025-3-26 16:53
Einleitung: Laser in der Umweltme?technikring genes into somatic mammalian cells have been developed and have led to a range of gene therapy clinical trials for both inherited and acquired disorders. The majority of clinical trials have used viral vectors of animal origin to mediate gene transfer, with retroviruses, adenoviruses and adeno-作者: SHRIK 時間: 2025-3-26 22:18
https://doi.org/10.1007/978-94-017-0926-2biochemistry; biotechnology; chemistry; chromatography; gene therapy; protein作者: Iniquitous 時間: 2025-3-27 03:43
978-90-481-5237-7Springer Science+Business Media B.V. 1999作者: Bph773 時間: 2025-3-27 09:09
S. Z. Lee,E. Geissler,H. W. BergmannGeneral validation principles are explained. Documentation requirements and the practical organisation of a validation project are described. The specific considerations for qualifying biopharmaceutical equipment and processes are described.作者: 百科全書 時間: 2025-3-27 11:49
U. Griebner,R. Grunwald,R. KochThis chapter discusses design and validation of Water for Injection generation and distribution systems. It covers not only the validation activities required for new systems, but also the approach taken for existing systems.作者: LEERY 時間: 2025-3-27 14:06
Abstimmbare Mikrokristall-LaserThis chapter reviews bibliographic sources of information relevant to the biopharmaceutical industry and describes their evolution from printed indexes to electronic services deliverable to the desktop.作者: 夸張 時間: 2025-3-27 20:49 作者: 死貓他燒焦 時間: 2025-3-27 23:25
Biopharmaceutical Validation: an overview,General validation principles are explained. Documentation requirements and the practical organisation of a validation project are described. The specific considerations for qualifying biopharmaceutical equipment and processes are described.作者: lactic 時間: 2025-3-28 05:01 作者: 你不公正 時間: 2025-3-28 09:54 作者: accomplishment 時間: 2025-3-28 13:19
Information technology and the internet as a resource of biopharmaceutical information,The vast quantities of scientific data modem technologies and computer driven analytical equipment now generated renders data storage and analysis by traditional means almost impossible. This chapter explains how such information may be stored and analyzed electronically and overviews major sources of bioinformation on the internet.作者: 絕食 時間: 2025-3-28 17:55
Marketing Issues for the (Bio)pharmaceutical sector, use. It is often fruitless and costly to begin developing marketing programs and spending money in advance of making careful and global strategic assessment. This chapter focusses on this and related issues central to the successful marketing of (bio)pharmaceutical products.作者: Colonnade 時間: 2025-3-28 22:13
http://image.papertrans.cn/b/image/188318.jpg作者: neutralize 時間: 2025-3-29 00:07
Laser in der Technik / Laser in Engineering use. It is often fruitless and costly to begin developing marketing programs and spending money in advance of making careful and global strategic assessment. This chapter focusses on this and related issues central to the successful marketing of (bio)pharmaceutical products.作者: 有幫助 時間: 2025-3-29 06:26
Biopharmaceuticals, an overview,bstances produced by modem biotechnological techniques. Thus far, in excess of 50 such substances have gained regulatory approval for medical use. All are proteins produced by recombinant DNA technology or (in the case of monoclonal antibodies) by hybridoma technology..Biopharmaceuticals approved to作者: 跟隨 時間: 2025-3-29 09:49
Abciximab: The First Platelet Glycoprotein IIb/IIIa Receptor Antagonist,rdial infarction and unstable angina pectoris. Although aspirin has traditionally been the mainstay of antiplatelet therapy, it is neither potent nor specific enough to provide adequate protection against thrombosis. The identification of glycoprotein (GP) IIb/IIIa as the key platelet receptor in th作者: 價值在貶值 時間: 2025-3-29 12:02 作者: Pandemic 時間: 2025-3-29 15:48 作者: Promotion 時間: 2025-3-29 21:09
Follitropin beta (Puregon),were transfected with genes encoding for the α- and β- subunit of FSH. The production of the amino-acid backbone and the very essential post-translational glycosylation process results in a human FSH virtually identical to natural human pituitary FSH. In clinical trials it was shown that this recomb作者: CODE 時間: 2025-3-30 00:39 作者: 揉雜 時間: 2025-3-30 08:07 作者: neutralize 時間: 2025-3-30 11:33 作者: Transfusion 時間: 2025-3-30 14:00
Stabilisation of biopharmaceutical products and finished product formulations,m a clinical and regulatory point of view. Furthermore, the stability profile should cover the manufacturing and marketing cycles of the product to minimise costs. The major routes by which proteins may be degraded are outlined. A brief description of biopharmaceutical production processes is provid作者: 鍵琴 時間: 2025-3-30 19:01
Patent Law for Biopharmaceuticals,stry, and biotechnology in all their many sub-categories. To be patentable, biopharmaceuticals and their processes of manufacture have to meet the same three legal tests of novelty, inventiveness, and practical utility as do the simpler compounds and preparative methods of synthetic chemistry. As fo作者: FIR 時間: 2025-3-30 21:12 作者: 宿醉 時間: 2025-3-31 01:02 作者: 脾氣暴躁的人 時間: 2025-3-31 06:24 作者: 殘酷的地方 時間: 2025-3-31 09:54
Marketing Issues for the (Bio)pharmaceutical sector, use. It is often fruitless and costly to begin developing marketing programs and spending money in advance of making careful and global strategic assessment. This chapter focusses on this and related issues central to the successful marketing of (bio)pharmaceutical products.作者: ANTIC 時間: 2025-3-31 15:48 作者: 刪除 時間: 2025-3-31 17:50
lsorenders it an ideal reference source for students undertaking advancedundergraduate or postgraduate courses in biotechnology, pharmaceuticalscience, biochemistry or medicine.978-90-481-5237-7978-94-017-0926-2作者: Corral 時間: 2025-4-1 00:00 作者: 未開化 時間: 2025-4-1 04:59 作者: 纖細(xì) 時間: 2025-4-1 06:42
Laser in der Medizin / Laser in Medicineturing process includes four chromatographic separation procedures and two filtration procedures to remove impurities and potential contaminants. The identity, purity, potency, safety, and quality of rFIX drug substance are ensured by a series of test procedures, including gel electrophoresis, size-作者: guardianship 時間: 2025-4-1 12:30
Ureterotomy with a pulsed Holmium Laseregard to its earlier relapsing-remitting form, which is marked by reversible exacerbation, and subsequently also in secondary progressive MS with its increasing physical and especially motor disability. We describe the development, clinical effects and side effects as well as the mode of action of t作者: 不妥協(xié) 時間: 2025-4-1 14:48 作者: moratorium 時間: 2025-4-1 21:57
M. Klein,H. P. Dauben,H. D. Schulte,E. Gamsuch an important role in research. Today the drug development process has become a disciplined, modem science and this has occurred, almost entirely, in the last 40 years and at an ever increasing rate. If one looks back to just before the second world war, there were no antibiotics, no anti-hyperte
